Jump to content

Hirayama Disease

""Original Editor ""- Rishab Mishra ""Top Contributors" - Rishab Mishra

Introduction

Hirayama disease is referred to by different names when it affects only one limb and leads to the gradual wasting of muscle tissue. It is most common in young males compared to females and is more prevalent in Asian countries. According to various studies, it has been proven that the condition is caused by the compression of one side of the cervical spinal cord by the dural sac of the cervical spine during neck flexion.[1]

Prevalence

  • Hirayama disease is typically found in individuals between the ages of 15 and 25.
  • It is more common in males compared to females.
  • Initially, it affects one side of the upper limb and gradually progresses to the other limb.
  • It is observed predominantly in Asian countries.
  • The symptoms of this disease take several years to manifest, which significantly delays the diagnosis process.[2]

Characteristic/clinical representation

  • The primary characteristic observed is the weakening of the muscles in the distal part of the hand.
  • A sharp, shooting pain often radiates from the cervical spine to the arm.
  • The temperature of the hands tends to drop, and the muscles fatigue easily.
  • Gradually, the weakness spreads to other parts of the body, starting from the upper limbs and progressing to the lower limbs.[2]

Associated comorbidity

  • Sympathetic and parasympathetic dysfunction, motor pathway impairment, and skeletal muscle dysfunction (e.g. muscle weakness) are commonly observed.[3]

Medication

cervical collar or surgery[4]

Diagnostic test

Cervical spine © Nevit Dilmen, CC BY-SA 3.0 <https://creativecommons.org/licenses/by-sa/3.0>, via Wikimedia Commons
  • Neurophysiological testing[5]
  • Advanced imaging techniques[6]

Etiology

Pathogenesis of Hirayama Disease

The exact mechanisms underlying Hirayama disease are multifactorial and not fully understood. Several theories have emerged to explain its development.[7]

Contact Pressure Theory

Early cadaveric studies suggested that degenerative spurs compress the spinal cord during flexion, contributing to the disease's progression.[7]

Tight Dural Canal Theory

The most widely accepted theory proposes that increased laxity of the dura mater, particularly during cervical flexion, allows anterior displacement of the spinal cord. This displacement leads to repeated episodes of subclinical cervical trauma, resulting in micro-ischemia and eventual myelopathy.[7]

Growth Imbalance Hypothesis

Research suggests that an imbalance between vertebral column growth and dural canal development may contribute to increased laxity. This imbalance, particularly pronounced during growth spurts, enables anterior displacement of the posterior dura.[7]

Medical management

Although Hirayama disease is self-limiting, its long-term effects necessitate treatment. The primary goal is to halt disease progression and alleviate symptoms.

Conservative Management

Initial treatment involves:

1. Cervical collar use for 3-4 years to restrict neck flexion and cervical movement.

2. Physiotherapy to strengthen posterior cervical extensors, improving cervical sagittal alignment.[7]

Surgical Intervention

Reserved for advanced, severe, or refractory cases with:

1. Atypical muscular involvement.

2. Significant spinal cord atrophy on MRI.[7]

Surgical options include:

1. Duroplasty with tenting.

2. Cervical decompression with fusion/fixation.[7]

Surgical Approaches

1. Anterior cervical discectomy with fusion and plating (ACDF) shows optimal outcomes.

2. Maintaining physiological local lordosis angle is crucial to prevent adjacent segment disease.[7]

Classification and Treatment Guidelines

The Huashan classification system categorizes Hirayama disease into:[7]

1. Type 1: Hand and forearm muscle atrophy (stable or progressive).

2. Type 2: Atrophy with pyramidal tract damage.

3. Type 3: Atypical presentations.

Treatment recommendations:

1. Conservative approach for Type 1 and 3.

2. Surgical intervention for Type 2.

Modified Delphi technique-based guidelines provide standardized diagnosis and treatment protocols.[7]

Physiotherapy treatment

Neck strengthening https://creativecommons.org/licenses/by-sa/3.0/
Neck strengthening https://creativecommons.org/licenses/by-sa/3.0/

Strengthening Exercises: The programme included isometric neck strengthening and resistance training for the forearm, wrist, and hand muscles.[8]

  • Improvement in Grip Strength: This improvement signifies enhanced muscle function and strength in the affected areas.[8]
  • Enhanced Activities of Daily Living (ADLs): The physiotherapy programme led to better performance in daily activities.[8]
  • Postural Correction: Treatment involved postural correction techniques, which are crucial for managing Hirayama disease (HD). Maintaining a neutral neck position and using a cervical collar helped slow disease progression and prevent further complications.[8]
  • Prevention of Complications: Physiotherapy played a vital role in preventing immobility-related complications such as joint stiffness and muscle wasting. This is particularly important in a self-limiting disorder like HD, where maintaining mobility is essential for overall health.[8] In summary, physiotherapy for Hirayama disease not only improved muscle strength and grip but also enhanced the patient's ability to perform daily activities, thereby improving their quality of life.[8]

Refrences

  1. ↑ Lay SE, Gudlavalleti A, Sharma S. Hirayama disease.
  2. ↑ 2.0 2.1 Hirayama disease. (2024, July 19). In Wikipedia. https://en.wikipedia.org/wiki/Hirayama_disease
  3. ↑ Anuradha S, Fanai V. Hirayama disease: a rare disease with unusual features. Case Reports in Neurological Medicine. 2016;2016(1):5839761.
  4. ↑ Yagi K, Kinoshita K, Hara K, Matsubara S, Uno M. Markedly improved function in severe Hirayama disease by anterior cervical fusion: A case report. Interdisciplinary Neurosurgery. 2020 Sep 1;21:100738.
  5. ↑ Ay H. Hirayama disease (monomelic amyotrophy) clinically confused for carpal tunnel syndrome. Neuropsychiatric disease and treatment. 2017 May 22:1385-8.
  6. ↑ Lee KW, Kim T, Kim SH, Hong YJ, An JY. Hirayama Disease with Isolated Spinal Cord Atrophy. Journal of Neurosonology and Neuroimaging. 2023 Dec 31;15(2):114-6.
  7. ↑ 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 Hirayama Disease Sara Lay; Aashrai Gudlavalleti; Sandeep Sharma.https://www.ncbi.nlm.nih.gov/books/NBK499913/
  8. ↑ 8.0 8.1 8.2 8.3 8.4 8.5 Physiotherapeutic management of hirayama disease A case report Patel, Lilima; Sarkar, Bibhuti1; Oraon, Anil Kumar2,https://journals.lww.com/iaph/fulltext/2022/16010/physiotherapeutic_management_of_hirayama_disease_.8.aspx#:~:text=Introduction-,Hirayama%20disease%20(HD)%20is%20a%20rare%20condition%20which%20is%20also,atrophy%20of%20unilateral%20upper%20extremity